Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
about
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transportIntimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy.The adoption of Mediterranean diet attenuates the development of acute coronary syndromes in people with the metabolic syndromeCentile values for serum lipids and blood pressure for Asian Indian adolescents.Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusApolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activatorsThyroid hormone regulates the hypotriglyceridemic gene APOA5Antidiabetic effects of Brucea javanica seeds in type 2 diabetic ratsLeft ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study.Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.Search for genetic factors predisposing to atherogenic dyslipidemia.Association of branched-chain amino acids with carotid intima-media thickness and coronary artery disease risk factors.Empirically derived phenotypic subgroups - qualitative and quantitative trait analyses.Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia.Effects of walnut oil on lipid profiles in hyperlipidemic type 2 diabetic patients: a randomized, double-blind, placebo-controlled trialNon-high-density lipoprotein fractions are strongly associated with the presence of metabolic syndrome independent of obesity and diabetes: a population-based study among Iranian adultsInsulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.Examining the gender difference in the association between metabolic syndrome and the mean leukocyte telomere lengthScreening for diabetes using Japanese monitoring guidance in schizophrenia patients treated with second-generation antipsychotics: a cross-sectional study using baseline data.Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease.Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other DyslipidemiasIs hypercholesterolemia a risk factor and should it be treated in the elderly?Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect RatioA major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans.Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategiesMediterranean diet and cardiodiabesity: a review.Extracellular nucleotides inhibit insulin receptor signaling, stimulate autophagy and control lipoprotein secretion.Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL.The effect of combination therapy of allicin and fenofibrate on high fat diet-induced vascular endothelium dysfunction and liver damage in ratsInsulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies.A cross-sectional study of the prevalence and risk factors for hypertension in rural Nepali women.The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution.Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl estersPerspectives: The significance of measuring non-HDL-cholesterol.Morphological changes of parotid gland in experimental hyperlipidemia.Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels.Evaluation and management of dyslipidemia in patients with HIV infection.Fermentation of soy milk via Lactobacillus plantarum improves dysregulated lipid metabolism in rats on a high cholesterol diet.Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.
P2860
Q24603087-04F2BCC6-1295-4338-87F9-51684856036EQ24796491-5F47F0EC-091D-44F7-B515-DA06FF86DC0AQ24797266-F3DB63B9-570B-42B1-9FE5-F681F1A249FDQ24815489-7F5FB196-D8AA-409B-9F65-19E279D9B2D6Q26829529-BD89419A-874D-445C-9753-DC6949A0DBBCQ28183207-F114115C-CDDA-4499-93CD-65538872DF28Q28569807-E5AB7F54-64BB-467D-AB4D-78F604E51894Q28817360-E1533244-4A5A-409C-8267-5EA760A2D5CCQ30440409-F136E6D8-86C5-4A5D-8C4E-AB32EBA7651FQ30759526-C8DDEEC1-DB9F-4BAB-B631-9C6B14E027E8Q31049239-D7387CD4-1C3B-4E1F-989B-C16C0BE59B6EQ31164987-1A966848-86BE-46A5-BE32-A558FB3F32E6Q33198443-21794540-18F8-4D54-A532-0D6D67CA1A24Q33212773-3E9863D9-F13D-4DA2-B66E-85919B20A9B7Q33701908-9F6131C3-5024-40D0-80BB-A86B48D1AF98Q33776151-12347AE4-C63A-4F09-81E5-9CD515D5F6B2Q33823946-C80A4C12-4B6D-4187-883E-C8271062FB66Q33884203-2E69E2CC-94D7-4BAE-98E4-429EA217CB31Q33890480-B09CC75D-5EA4-4993-AE7F-4D853801FE8FQ34015104-235BC31B-4B64-4E0A-A2E9-E03E78ABA197Q34037840-3BCF7E4C-6DDB-4931-80C9-FAF4F5B76871Q34077942-5176915C-6AD3-4AFD-9A6D-AA4AB3A37A6AQ34095816-E70A779A-4222-409A-ACDC-B4FEF0CF3D6BQ34145532-DDB8A70A-170C-4AE1-ADE5-D9C313E0EFDDQ34245190-ACB62E8E-61C2-4866-8EC7-D04D7CB44720Q34263468-5A2B7179-8763-4951-938B-22CD8C6EDDBFQ34271095-2C48A256-4F3D-4F7D-B137-45259D8156BBQ34377359-F441CDCB-C316-48D8-936D-F34AC8D41509Q34388041-2D9721AB-4194-4AF1-AE12-DC1BBDEF915EQ34391968-D6F3AC5B-2F33-4978-B0EC-60A5B9EDCEF9Q34508706-A1A399BD-6FB7-419F-9ED3-95C98E355A2DQ34556144-947F2CFC-F55B-496B-9CA1-B644262DB9E5Q34564466-70A9557A-13C8-402C-88FA-AEF5B4AE94ECQ34703867-CDCE9AF9-A889-4E85-B6E3-95DFD1C5D57CQ34714735-B099B021-85C3-4551-A95C-2A30458FC4B3Q34725583-55476758-BAD1-428A-BFEE-14501F944F81Q34734554-8F014742-8EBA-4326-ACD8-D81EF492B0BAQ34743413-52071069-A0EB-404E-9805-801701C09FD7Q35092731-30AF0EAD-1224-460C-98AA-D8C4FF0EF3E6Q35595343-4D1AEA0D-C8BA-46EF-818A-3E733CBFFB4C
P2860
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
@en
type
label
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
@en
prefLabel
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
@en
P921
P1476
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
@en
P2093
S M Grundy
P304
P356
10.1016/S0002-9149(98)00033-2
P407
P577
1998-02-01T00:00:00Z